Stepped wedge designs (SWDs) have received considerable attention recently, as they are potentially a useful way to assess new treatments in areas such as health services implementation. Because allocation is usually by cluster, SWDs are often viewed as a form of cluster-randomized trial. However, since the treatment within a cluster changes during the course of the study they can also be viewed as a form of crossover design. This article explores SWDs from the perspective of crossover trials, and designed experiments more generally. We show that the treatment effect estimator in a linear mixed effects model can be decomposed into a weighted mean of the estimators obtained from i) regarding a SWD as a conventional row-column design, and ii) a so-called vertical analysis, which is a row-column design with row effects omitted. This provides a precise representation of "horizontal" and "vertical" comparisons, respectively, which to date have appeared without formal description in the literature. This decomposition displays a sometimes surprising way the analysis corrects for the partial confounding between time and treatment effects. The approach also permits the quantification of the loss of efficiency caused by mis-specifying the correlation parameter in the mixed-effects model. Optimal extensions of the vertical analysis are obtained and these are shown to be highly inefficient for values of the within-cluster dependence which are likely to be encountered in practice. Some recently described extensions to the classic SWD incorporating multiple treatments are also compared using the experimental design framework.
Introduction
Stepped wedge designs (SWDs) have recently received an increasing amount of attention, largely as a design for the evaluation of service delivery and implementation [1, 2] . The typical design, shown in Table 1 for six time periods and five sequences, denoted by SW (5) , reveals the key features of the basic SWD: the trial is divided into successive time periods and into sequences, with the experimental units being randomly allocated to one of the sequences. All sequences start with the standard treatment in the first period and then change to the new treatment in a subsequent period, the change-over occurring at different times in the different sequences, but with the new treatment administered in the final period of all sequences. The number of sequences in these designs corresponds to the number of 'steps', i.e. occasions on which the standard treatment changes to the new [3] . Features which make the design attractive for the assessment of service implementation are i) that all sequences start with the standard and finish with the new treatment and ii) once the changeover to the new treatment has occurred it is impossible to revert to the standard treatment. Table 1 . Standard stepped wedge design, SW(5), with T = 6 periods and S = 5 sequences comparing treatments 0 (standard) and 1 (new).
The experimental units are usually groups or clusters of patients, such as general practices, hospitals, care homes, rural communities or schools, rather than individual patients [1, 2] . Consequently SWDs are often viewed as a variant of the standard cluster-randomized trial. While many aspects of SWDs can profitably be seen in this light, the fact that they are divided into successive treatment periods and units are allocated to sequences of treatments, means that they also have much in common with crossover (CO) trials [4] . The purpose of this paper is to explore the extent to which the perspective of COs and, more generally, classical designed experiments, can illuminate statistical aspects of SWDs. For example, the literature on SWDs has loosely described 'horizontal' and 'vertical' comparisons (see, e.g., [5] ) but without those being defined formally. We show that these can be defined explicitly using experimental design concepts and language.
In the next section we provide background on classical row-column designs and their relationship to SWDs. Section 3 provides a decomposition of the stepped wedge (SW) treatment effect under a linear mixed model with a variety of dispersion structures. Section 4 derives the variance of the SW treatment effect estimators under the correct and misspecified models of the dispersion structure, and examines the impact of mis-specification. In Section 5 we derive optimal weights for the so-called 'vertical' analyses and Section 6 considers recently proposed extensions to multiple treatments and derives the relative efficiency of treatment effect estimators under different designs. The paper concludes with a discussion of the issues raised.
Stepped wedge designs as a classical row-column designs
The principal concerns for analyses of SWDs is that account should be taken of i) the fact that the designs extend over time and so there may be systematic time effects in the observed responses, and ii) that individual responses clustered within higher levels units are correlated. In the analysis of a CO study there are analogous concerns which are addressed by the use of period and patient effects. In addition the literature on CO designs often considers a term for the carryover effect of treatments but, for many medical applications, the appropriateness of the standard carryover model has been questioned (see [6] ). For SWDs there are issues related to carryover [7] but they are of a somewhat different character and we will defer discussion of these until Section 7. Recent usage of CO designs in medical applications excludes carryover by using washout periods and in these circumstances a carryover term is not present in the model, so crossover designs are then essentially row-column designs, which we now describe.
In a row-column design, such as a Latin square or a Youden design, the aim is to arrange the treatments amongst the rows and columns so that i) the study can provide estimates of the treatment effects, notwithstanding the presence of row and column effects, and ii) that these estimates should have the best precision possible. Row-column designs in which J. N. S. Matthews and A. B. Forbes Statistics in Medicine each treatment is replicated as nearly equally as possible within each row, and also within each column, will provide high precision estimates, and are often optimal with respect to appealing criteria. The most familiar example of an optimal row-column design is the Latin Square, but there are many more flexible row-column designs with optimal properties, such as Generalized Youden Designs (GYDs) (see, e.g. chapter 4 of [8] ). Consider, for example, the two-treatment GYD shown in Table 2 , where each treatment appears three times in each row and two or three times in each column (i.e. as nearly equally as possible): denote this design as NrO. Row and column effects can be eliminated from the treatment comparison in both SW (5) and NrO, but the more balanced layout of NrO allows this to be done more efficiently, and it is worth considering for a moment the details of how this is achieved. Table 2 . A Generalized Youden Design, denoted NrO, with S = 5 rows and T = 6 columns, having the same treatment replication as SW(5).
Time
When contrasting SWDs and row-column designs a notation that is more commonly seen with the former than the latter will be adopted. Therefore the rows will be indexed by s = 1, . . . , S, as these correspond with sequences in the SWD, and columns are indexed by t = 1, . . . , T as these correspond to successive periods, or time. If a single outcome Y st were observed in row s and column t of the designs in Tables 1 and 2 , then the usual model for a row-column design, adapted for the two-treatment case, is
with fixed row effects α s , fixed column effects β t , treatment indicator D st ∈ {0, 1}, and mutually independent errors η st with mean 0 and variance σ 2 η . In the statistics literature, as well as the econometrics literature for panel data, such a model is called a two-way fixed effects model. The least squares estimator of the treatment effect θ is a linear combination of the observations,θ =
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The coefficients in Table 3 sum to zero down the columns, thereby eliminating column effects β t , and the rows sum to Table 3 (a), where reversing the order of the columns and of the rows yields the original matrix multiplied by -1. Inspection of the elements in Table 3 (a) shows that the layout of SW (5) requires that the observations are combined with very different weights and in a rather unintuitive way: for example Y 12 is given fourteen times the weight that is given to Y 25 , and Y 30 and Y 36 are omitted altogether. This feature is attributable to the unbalanced nature of the SWD, in that treatment and time are partly confounded -something which is less marked for the more balanced design NrO, where the weights vary much less.
Also,
Compared with NrO, which is the optimal design [8] for this number of rows, columns and treatments, the SWD has efficiency of only 32% (0.14/0.43), which quantifies the substantial loss of efficiency arising from the temporally imbalanced nature of the SWD.
If the model (1) is amended so that the row term α s is omitted, then the coefficient matrix changes to a C st , as shown in Table 4 (the corresponding table for NrO is unchanged, as the treatment and row effects are orthogonal in this design). The variance of this estimator of θ is 1 /4σ 2 η , which is substantially smaller than 3 /7σ 2 η (provided that σ 2 η has the same value in both models, as would occur if the model including the α s were inappropriate) and illustrates the penalty which has to be paid to eliminate simultaneously row and column effects in such an unbalanced design. This is despite the fact that the coefficients in Table 4 show that the first and last observations in each row are ignored in this estimator. Nevertheless, the unequal incidence of treatments in each column still exacts a price because this variance is nearly twice that for NrO. The analysis implied by the coefficients in Table 4 compares the mean of the observations on treatment 0 with the mean of those on treatment 1, separately within each column. Under the amended model (1) the resulting T columnwise estimators of θ are independent and Table 4 essentially prescribes how these are to be combined, namely by being weighted inversely to their variances. Such an analysis closely resembles the the so-called vertical analyses mentioned in the context of SWDs, see [5] . As is remarked in [5] , if observations in successive columns are dependent, it may be better if the separate column-wise contrasts are combined differently from the way implied in Table 4 , a point taken up in Section 5.
Vertical analyses, being based on within-column contrasts, are sometimes recommended since they preserve the randomization, because in a SWD units are randomized to rows not columns. As mentioned in [5] this is also true of analyses based on the coefficients in Table 3 (a), which can be viewed as aggregations of within-column contrasts, albeit The link between the above discussion and SWDs as they are usually implemented is not immediate, because the formulation implied by (1) is not used for SWDs. In particular, clusters, not individuals, are allocated to sequences and responses within clusters are generally correlated. A more realistic formulation denotes the continuous response of an individual j, in the ith cluster allocated to sequence s, observed in the tth period by Y sijt : the treatment administered in that period will depend on the sequence s to which cluster i has been allocated. While the same cluster is repeatedly measured throughout the study, the question arises of whether the individuals are measured on several occasions or just once. This will depend on context, as noted by Turner and colleagues [9] in the context of a cluster CO design. For the moment we assume that the application is such that each individual is measured just once, in a particular cluster and period, and as such there are separate samples of individuals in each period in each cluster. Also for simplicity it will be assumed that the same number of individuals, n, are observed in each period in each cluster, and that an equal number of clusters, N , is allocated to each of the S sequences in the design. A widely used model for the outcomes Y sijt was proposed by Hussey and Hughes [10] , namely
where the number of periods, T , will be S + 1 for designs such as those in Table 1 , although this need not hold for variations on this design. In this model β t is a fixed period effect, equivalent to the column effect, and D st is as in (1), and θ is the treatment effect. The cluster effect is described by a random term α si (as opposed to the fixed α s in (1)), independent of the individual residuals sijt ; both terms have zero mean and variances τ 2 and ν 2 , respectively.
Estimation of the β t and θ can proceed directly using maximum likelihood if we assume that the random terms in (2) are Normally distributed, or otherwise using a generalized estimating equation (GEE). However, an equivalent and more helpful form of the equations for the estimation of β t and θ can be derived by starting from the model implied for the cluster/period means,Ȳ sit = n j=1 Y sijt /n, namelȳ
X s is the design matrix for the fixed effects, which has a common value for all clusters i allocated to sequence s, then standard results on mixed models show that
Here V is the variance ofȲ si , and although a general form could be envisaged, we focus on that induced by (3) which is n −1 ν 2 I T + τ 2 J T,T , where I T is the T × T identity matrix and J T,T is the T × T Statistics in Medicine J. N. S. Matthews and A. B. Forbes matrix of ones. In the following it will often be convenient to write V as σ
note that ψ, the correlation of the cluster-period means, depends on n. This is in contrast to the usual measure of dependence encountered in cluster randomized trials, the intra-cluster correlation (ICC),
, the correlation between individuals in the same cluster that is induced by (2) . Notice that
, so the dependence on n means that ψ can take substantially larger values than are commonly encountered for ICCs: e.g. ρ = 0.1 corresponds to ψ = 0.36 for n = 5 and to ψ = 0.85 for n = 50.
From (4) it is seen that estimates of β t and θ are appropriate linear combinations of the means of the observations in each cell of the design in Table 1 . An explicit formula forθ is given in Appendix 2, where it is also shown that the coefficient matrix forθ from (4), a st , a function of ψ, is a weighted mean of the coefficient matrices for the vertical analysis, a C st , and the row-column matrix, a RC st , namely
, a quantity which has an important role in [3] (denoted therein by R), and Q is determined by the layout of the design and is defined in Appendix 1 -for SWDs of the form in Table 1 with T periods, Q = corresponds to no cluster effect in (3), the estimator is that from the conventional model with no row effect. On the other hand, if nτ 2 is large, then the between-cluster variation dominates and the smallest variance forθ will arise from estimators that are largely based on within-cluster contrasts, and in the limit as b → 1 the estimator coincides with that from the row-column design. Equation (5) allows coefficient matrices to be computed for any T : in Table 5 we illustrate the cases with six and four periods. The pattern of coefficients is similar between the four and six period versions: the columns, but not the rows, always sum to zero; the rows sum to zero only when ψ = 1; when ψ = 0 the first and last periods are ignored. For intermediate values of ψ the row sums tend to zero as ψ increases, and observations from the first and last periods begin to contribute toθ. Notice that the observations from the first and last periods of the middle sequence (i.e. the sequence with equal replication of 0 and 1) are ignored in all analyses: this does not apply when T is odd. Note also that for all ψ the coefficient matrix has symmetry arising from the time-reversible nature of the design, namely a st = −a S+1−s,T +1−t : the matrices in Table 5 are based on a temporally reversible V , and this symmetry may not obtain if this were not the case.
Model extensions
The model (2) is suitable for the case where the nT measurements in a cluster arise from nT different individuals, each measured once. If the nT observations arise from T serial measurements on each of n individuals as would be the case in a closed cohort design [7] , i.e. if the data are longitudinal, then an alternative model is needed. A suitable extension is
where ξ sij is a random effect for each individual, with zero mean and variance ω 2 , independent of the other random terms. A further extension is when the period effect can vary randomly between clusters, i.e. β t in (6) is replaced by β t + φ sit , where φ sit are independent random variables, also independent of the other random terms and with zero mean and variance δ 2 . This would be important if the way time affects the outcome differs between the clusters, for example because of differences in their location. Both of these elaborations of the model in (6) have been considered by others, e.g. [3, 11] . Table 5 . Coefficient matrices for designs SW(5) and SW(3) analysed with random effects with V ∝ (1 − ψ)I 6 + ψJ 6, 6 (Scalings chosen so that entries to 1 d.p. are exact)
Under this model the vector of N SnT responses has dispersion I N S ⊗ Ω where Ω is the nT × nT dispersion matrix of the responses on a cluster, and
From this it follows that the dispersion of the Tdimensional vector of mean responses on a cluster allocated to sequence s,Ȳ si is (n
i.e. the same form as for the cross-sectional design, but with τ 2 replaced by τ 2 + n −1 ω 2 , and ν 2 by ν 2 + nδ 2 . More detailed algebra shows that in the longitudinal case, and for dependencies of the form induced by the model in (6), the estimates of γ are of the form in (4), but now with ψ = (nτ
, in the definition of V . Consequently the above coefficient matrices also apply to the longitudinal case, provided that the appropriate adjustment is made to ψ.
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Variance of the treatment estimator under a variety of models
In this section an expression for the variance ofθ is derived in terms of the coefficient matrix and this is used to explore the effect of mis-specification of the dispersion structure. To be specific it is supposed that the true ICC is ρ, while that used for estimation of θ is ρ . The notation for the matrix in (5) is extended to a st (ρ) in order to make explicit the correlation used in the estimation. Strictly speaking a st is a function of ψ, which depends on both ρ and n, however the dependence on ρ is emphasised and that on n is suppressed, as mis-specification in the ICC ρ is more pertinent and familiar to practitioners. While the results apply to both cross-sectional and longitudinal cases, the exposition below will be in terms of the former. If we write the S × T coefficient matrix in (5) as a(ρ), where (a(ρ)) st = a st (ρ), then the estimator of θ found when the correlation is taken to be ρ isθ
where (Ȳ s ) t is element t ofȲ s and a s (ρ ) is the sth row of the coefficient matrix a(ρ ). The subscript ρ has been added tô θ to emphasise the dependence of the estimator on ρ . The true variance ofȲ s is 1 N V , so it follows that
where tr denotes the trace of the matrix. If the true variance has the equicorrelation pattern induced by (2), namely (7) can be expressed as
As a(ρ ) can be written in terms of a RC and a C , using (5), this expression becomes
where
and
. . , A 4 and Q are known values determined by the layout of the design, and values for classic SWDs, as in Table 1 , are given in Table 6 for a range of T . Note that for the cases ρ = 0, 1,
Analyses based on ρ = 0, corresponding to the vertical analysis, on ρ = 1, corresponding to the row-column analysis and on ρ = ρ, being the optimal analysis with no mis-specification, are considered. So too are analyses based on perturbed values of ρ, namely ρ = k ±1 ρ, for k = 2. For these values of ρ Figure 1 shows the normalised variances,
, for four examples, based on SW(3), SW(9) with n = 5, 50. The ICC in Figure 1 ranges up to 0.3, which is considerably larger than is usually encountered in practice, but is sufficiently small that kρ < 1. Figure 1 confirms that the mixed-model estimator (4) using the true correlation for ρ has the smallest variance. Even when ρ is perturbed from the true correlation by a factor of 2 the effect on the variance is small: for clarity, only underestimation, which gives slightly larger variances, is shown in the figure. For T = 4, n = 5 the maximum over ρ ≤ 0.3 of the ratio of the variance when ρ = kρ to ρ = ρ is 1.060 for k = larger variance, because it is attempting to eliminate row effects that are, in fact, absent. With increasing clustering the variance of the vertical estimator increases markedly, and is too inefficient to be viable unless both n and ρ are small. The efficiency of the row-column estimator increases with increasing ρ; for ρ > 0.2 its variance is less than 10% (T = 4) and 6% (T = 10) larger than the optimal value when n = 5, and only 1% and 0.6% larger when n = 50.
Efficient vertical analyses
The so-called vertical analysis is based on the coefficient matrix a C : the 'vertical' aspect is that the columns alone sum to zero, so providing contrasts made between randomized groups in each period of the design. The first and last columns vanish because there is no variation between treatments in these columns, soθ based on a C is a weighted combination of the T − 2 non-trivial column-wise estimators. The estimator using a C weights the column-wise estimators inversely by their variance and is optimal in the case when the elements in a row are independent. Table 7 . Coefficient matrices for vertical analyses of designs SW(5): λ i chosen to ensure unbiassedness and minimum variance when there is within-row correlation In practice it is not possible to exclude within-row dependence in the outcomes. An alternative approach to providing a 'vertical' analysis is to use the coefficient matrix in table 7(b), where λ 1 , . . . , λ T −2 are chosen to minimise the variance ofθ, while maintaining unbiassed estimation of θ. In the following it will be convenient to defineã to be the S × (T − 2)-dimensional matrix obtained by omitting the first and last columns from a C . Also, suppose thatX denotes the S × (T − 2)-dimensional matrix of 0s and 1s showing the SWD, as in Table 1 , again with the first and last columns omitted. If the column weights λ 1 , . . . , λ T −2 are written as a diagonal matrix Λ, then the revised estimator,θ Λ is that obtained by usingãΛ as the coefficient matrix. Also
and for unbiassedness
where B =ã Tã andṼ is the dispersion matrix for the cluster means in periods 2 to T − 1, i. 
IfṼ is of the form
where diag(·) denotes the diagonal elements of its argument. Using this form it can be shown that (ω 1 diag(B) + ω 2 B)1 T −2 ∝ d, in other words for equicorrelation dependence, the optimum vertical analysis sets all λ i = 1, i.e. to use the vertical analysis derived in Section 2 based on a C . This does not have to apply ifṼ takes another form: for example with T = 6 and V having an autocorrelation structure with V ij = ρ |i−j| , then for ρ = 1 2 the optimal λs are 1.108, 0.929, 0.929, 1.108. However, in this case the distinction is slight, because the efficiency of the equally weighted analysis is around 99.6%.
The above indicates that for the equicorrelation structure the equally weighted vertical analysis, shown to be generally very inefficient in Section 4 is, nonetheless, the best of the extended vertical analyses exemplified in Table 7 (b). It is only slightly suboptimal amongst vertical analyses when an autoregressive dispersion model is assumed, which demonstrates that even the best extended vertical analysis is highly inefficient for some plausible dispersion structures.
Extended SWDs with multiple treatments
Row-column and vertical analyses
Although the classic form in Table 1 dominates the literature on SWDs, numerous variants are possible, several of which fit into the framework of the present paper. The extensions considered in this section are to designs where a standard treatment, 0, is compared with two new treatments, denoted by 1 and 2. There are several types of such designs, each potentially of use in a variety of settings. Lyons and colleagues [12] present and categorise various extensions of this type, and cite four trials where these extensions either have been used or might profitably have been used [13, 14, 15, 16] . The first extension is the concurrent design, shown in Table 8 for three periods, which is essentially two separate SW(2) designs each testing a different new intervention. Although these assessments could be made in two separate classic SW(2) designs, it may be sensible to combine them as each new treatment is compared with the same standard treatment, and if it is reasonable to believe that the same period effects extend across the two component SW(2) designs. In this case a suitable extension to the model in (1) is
where D kst = 1 if treatment k ∈ {1, 2} is allocated to cell (s, t), and 0 otherwise: here θ k is the effect of treatment k relative to treatment 0. Two further extensions considered in [12] are the replacement and supplementation designs, shown in Table 9 for the case T = 6. It is suggested [12] that the replacement design would be useful when there are two interventions to assess but Table 9 . Replacement and Supplementation designs for comparing two new treatments with a standard
which cannot be applied at the same time. It is conceded that there must be no carryover from the periods when intervention 1 is used into those when intervention 2 is employed. In many service implementation studies the new arrangements may take some time to become familiar, so a further use of the replacement design could be practical way to allow for this effect, by conceiving of treatment 2 as a mature version of treatment 1, as has been previously suggested [10, 17] . The supplementation design would be suitable when a second intervention requires that the first is present, or where the first cannot be removed once it has been implemented. Mathematically the design is largely the same as the replacement design, as from this point of view the difference between the designs amounts to a re-parametrization of the treatment effect. In the supplementation designθ 2 isθ 2 −θ 1 in the replacement design.
Other extensions are mentioned in [12] , such as a factorial design; the approach described below can also be applied to these designs and they will be explored elsewhere.
The row-column and vertical analyses described in Section 2 can be applied to these extended designs if the model in (10) is adopted. The estimator of (θ 1 , θ 2 )
T is derived in (A3) and, as for the two-treatment case, can be expressed in terms of coefficient matrices. These can be written in terms of the coefficient matrices for two sub-designs, D1 and D2 of a three treatment design D: cell (s, t) of D1(D2) is 1 if treatment 1(2) is applied in that cell and 0 otherwise. If the coefficient matrices for D1 and D2, regarded as two-treatment designs, are a(1) and a(2) respectively then the coefficient matrices for (θ 1 ,θ 2 ) from D can be written as θ 1
As a(1), a(2) are S × T matrices, the [] are a reminder that this equation must be interpreted formally, namely as the implied linear combination of the coefficient matrices: cf. (A4). The matrixM is
so, for example, the coefficient matrix forθ 1 is [a(1) − r 1 a(2)]/(1 − r 1 r 2 ). The elements r 1 and r 2 differ depending on whether the row-column or the vertical analysis is used. In addition, the dispersion matrix of the estimators can also be found as:
For the concurrent design the coefficients and dispersion matrices are shown in Table 10 for both the row-column and vertical analyses. The variance ofθ 1 from a design which comprised just the first two rows from Table 8 would be 3σ Table 8 were used. In this case the investigator would have to be persuaded that the period effects β t could be assumed to apply to the whole design, because it is the availability of information on these parameters from all the rows in Table 8 Table 10 . Coefficient matrices forθ 1 for the concurrent design in Table 8 : (a) row-column and (b) vertical analyses. The coefficient matrices for θ 2 are the same but with the first two rows interchanged with the second two rows. The dispersion matrices for (θ 1 ,θ 2 ) T for these models are shown below the coefficient matrices
The coefficient and dispersion matrices for the Replacement design (Table 9 (a)) are shown in Table 11 . As remarked in [12] , while the concurrent design givesθ 1 andθ 2 that have equal precision, the replacement design gives an estimate ofθ 2 which is notably less precise thanθ 1 . Although the two treatments are equally replicated, in the replacement design treatment 2 is more heavily confounded with period effects than treatment 1. The estimates of the two treatment effects are highly correlated in both row-column and vertical analyses. It is worth noting that the coefficient matrices in Table 11 contain a number of zeroes, corresponding to observations that will be ignored in the analysis. This is more marked for the vertical analysis but nonetheless there are a number of observations which contribute nothing even in the row-column analysis.
Replacement Design Table 11 . Coefficient and dispersion matrices for the row-column (a) and vertical (b) analyses of the six-period replacement SW design: note italicised disperson matrices in last row relate to the Supplementation design.
The corresponding results for the Supplementation design, Table 9 (b), are not shown because they are closely related to those for the Replacement design. In an obvious notation, θ Moreover this connection between the parameters allows the variances for the supplementation design to be found, as shown in italics in Table 11 : note that in this parameterisation θ 1 and θ 2 are estimated with equal precision and are markedly less correlated than for the Replacement design.
Random effects analyses
The random effects model described in Section 3.1 carries over to the extended designs in a natural way. If the analysis of an extended design D uses the correlation ρ and the coefficient matrices for the sub-designs D1 and D2 are a(ρ , 1) and Statistics in Medicine J. N. S. Matthews and A. B. Forbes a(ρ , 2) respectively, then the estimators for the treatment effects are
where nowM
and, as before, b = T nρ /(1 + (T n − 1)ρ ) and the Qs are defined at the end of Appendix 1. The dispersion matrix of (θ ρ 1 ,θ ρ 2 ) T also carries over from the uncorrelated case so, using the new form forM , we have from (11) that
where V is the true variance, as used in (7). Table 12 . Coefficient matrices forθ 1 for the three-period concurrent design in Table 8 using random effects model (left hand column). Although the matrices, a(ρ , 1), a(ρ , 2) are written in terms of ρ for consistency with Section 4, they are functions of ρ and n through ψ = nρ /[(1 − ρ ) + nρ ], which is used to index this If an investigator wishes to assess three treatments using the design D in Table 8 , then the treatment estimator can be based on an analysis of the whole design, using the coefficients in the left-hand column of Table 12 . An alternative approach would be to analyse the component designs separately, using the coefficients in the right-hand column of Table  12 . This might be adopted if the analyst is unsure if the period effects can be taken to be the same across D1 and D2. As Statistics in Medicine with the classic design, information from the first period is ignored when ρ = ψ = 0, but in the combined analysis, it is no longer necessary to ignore information from period 3. Again, when ρ = ψ = 1 the coefficients within a sequence will always sum to 0. For intermediate values the pattern of coefficients changes smoothly from one extreme analysis to the other.
Assuming that equal numbers are allocated to all the sequences in D, the variances ofθ 1 from the combined and separate analyses can be compared and the ratio of these two quantities is plotted in Figure 2(a) for the design in Table 8 . With this formulation the effect of mis-specification of ρ could be investigated, but this is not considered in Figure 2 where ρ is assumed to be equal to the true correlation ρ. The design in Table 8 combines two copies of SW (2), and Figure 2 also shows the results for the analogous designs based on SW(5) and SW (11) . The advantage of using the combined design reduces with increasing ρ but even for ρ close to 0.3 the separate analysis has a variance between 1.4 and 1.6 times larger, with the larger advantage occurring for shorter designs. If there is interest in estimating θ 1 − θ 2 then the combined analysis analysis offers a much more efficient estimator than simply taking the difference of the estimators from the separate analyses. The corresponding variance ratios forθ 1 −θ 2 are show in Figure 2(b) : while the overall pattern is similar, the ratios indicate a much larger advantage for the combined analysis.
Discussion
In stepped wedge trials the usual precepts of design theory have to be sacrificed to meet the practical constraints of the applications where they are typically used. Nevertheless a SWD is still an experimental design and some of its properties can best be understood by viewing it in this light. In particular, because of the marked non-orthogonality between the period effects and the treatment effect inherent in a SWD, it is useful for the triallist to understand how the observations are combined to provide a treatment estimator for each of the several forms of analysis that are available. The coefficient matrices derived in Sections 2, 3.1 and 6 allow the user to see how the information in the different cells of the table are combined to provideθ: Kershner and Federer [18] provided similar information for two-treatment crossover designs. The treatment estimators obtained from most designed experiments apply quite similar weights to the observations, as shown in Table 3 (b). This is not the case for SWDs: several of the coefficient matrices shown in the present paper reveal that many observations receive relatively low weight, or have coefficents with counterintuitive signs, and some observations are ignored altogether. Of course, more efficient and balanced designs, such as NrO, are not alternatives to SWDs because Statistics in Medicine J. N. S. Matthews and A. B. Forbes they do not fulfil some of the requirements such as treatments changing from 0 to 1 only once in a sequence, which in practice corresponds to a new intervention not being able to be withdrawn once it has been implemented. Nevertheless, it is important for users of SWDs to be aware of the statistical consequences of their choice of design.
The coefficient matrices presented in this paper assume that the number of clusters in a sequence, N , and the number of observations in each period within each cluster, n are constant. In practice this will not be the case, but i) departures will often be small, and ii) this assumption provides coefficients which are easily assimilated, thereby giving greater insight into the way SWDs provide information on the treatment effects.
For designs comparing two treatments the coefficients are often simpler for the vertical analysis. However, as Figure  1 shows, the vertical analysis produces the most precise estimator only if there is no variation between clusters. As the contribution of the between-cluster variation to the total variation in the cluster meansȲ is increases, the vertical analysis rapidly produces a very much less precise estimator than a mixed-effects or row-column analysis. Substantial values of ψ are likely to be a feature of many SWDs, especially those with larger values for n, so the efficient use of these designs will require the analyst to accept the unbalanced contrasts, such as those shown in Table 5 .
The results in Sections 3 and 4 are largely based on the form for V induced by (3), although similar results would obtain for the extensions described in Section 3.2. However there may be good reason to consider other forms for V , such as ones where cluster effects are less correlated the further they are separated in time. Such V could be used in (4) although analogues of the subsequent algebraic results would only be available if the revised V possessed an explicit inverse. We hope to report on the application of autoregressive processes to these designs in the near future.
The extended designs proposed in [12] and discussed in Section 6 represent quite a new line of work but may offer substantial advantages in certain contexts. In particular the concurrent design, running two SWDs in parallel, allows period effects to be eliminated more efficiently, and, if relevant, the two new treatments can be compared much more efficiently. The Replacement design, Table 9 (a), allows a second new treatment to follow the first. However, if it is not imperative that all clusters end the trial receiving the second treatment, then other forms of the design may have merit. For example, if the middle sequence in Table 9 (a) were permitted to be 0, 0, 2, 2, 1, 1, then var(θ 1 ) decreases by 8% and var(θ 2 ) by 49%; the large reduction for θ 2 is because in the new design there is much less confounding of the information on θ 2 with the period effect. If a need for designs of this kind were established, then further exploration of their precise form could pay substantial dividends.
Other forms of SWD have also been discussed, some of which fit into the framework derived above, such as hybrid designs [3] , where the classic SWD is supplemented with a number of sequences in which only treatment 0, or only treatment 1 is used, so it is a mixture of a SWD with a standard cluster randomized trial. In the classic SWD the number of periods is one more than the number of sequences, because the changeover from standard to new treatment advances by one period every sequence. However, this pattern can be modified, as shown in [3] and provided observations are made in every period and every sequence, the coefficient matrices can be derived using the methods in Section 2. Other patterns, such as periods where no observations are taken in some sequences, feature in some designs [19] , where such interludes are used to accommodate training sessions; the methods in Sections 2 and 3 would need some adaptations to deal with such cases.
The possibility that responses may vary over time, as well as because of changes in treatment, means that a model which allows for time effects is essential. The same is true of crossover trials, where the prudent analyst may wish to include period effects. The usual way that time is taken into account is through the term β t in (2). Non-standard approaches can be used if a specially tailored model can be identified for a particular application [20] , but this is the exception not the rule. In crossover trials empirically determined departures from the standard model are seldom encountered because crossover studies usually recruit too few subjects to permit a secure exploration of alternative models. The position with SWDs may be somewhat different, as these trials will often be much larger and the data might suggest models that are better than that in (2) . Allowing for time by replacing the categorical variables with a simple trend has been mentioned [12] as one possibility, although other forms might be contemplated. Moreover, it may be plausible in some applications to assume J. N. S. Matthews and A. B. Forbes Statistics in Medicine that the effect of time varies between clusters, as described in Section 3.2. Obviously there would be dangers in using the data from a particular study to determine its analysis, but as experience accrues in a particular field, useful information could emerge.
In the early development of crossover trials it was usually assumed that treatment effects might carry over into the immediately succeeding period, in a way described by a simple model [21] . More recently there has been substantial criticism of the applicability of such a model [6, 22] , and approaches in which carryover effects are excluded by nonstatistical methods, such as washout periods, have found favour. This is another aspect where the small size of crossover trials has inhibited attempts to identify alternative models by empirical exploration of data.
In classic SWDs something directly analogous to a carryover cannot arise because the new treatment is never followed by any other treatment (although issues may arise for the designs in Section 6). What can arise is that the effect of the new treatment changes in the time shortly after the changeover in treatments. Such an effect might happen if, for example, staff delivering a new treatment become more proficient as they become more accustomed to a new way of working [7] . Wash-in periods in SWDs, placed just after the change in treatment when staff get used to the new treatment but the data are not analysed, is a design device to mitigate this problem, analogous to the well-established use of wash-out periods in crossovers. An alternative approach [10, 23, 17] is to use (2) but with values of D st other that 0 or 1. For example fractional D st might be specified just after the treatment changes over, perhaps increasing to 1 in steps defined by the analyst. In such circumstances much of the work in the present paper would carry over with only minor adjustments. For example, the matrix a RC st is still more or less as implied by (A1), namely
with the obvious caveats that R 1 (C 1 ) are the row(column) sums of the D st and G 1 = s,t D st . The main change is that the first G 1 on the denominator of (A1) changes toG 1 = s,t D 2 st . Clearly G 1 andG 1 coincide when D st ∈ {0, 1} but not otherwise. Likewise, the formula for var(θ) in [10] can be used for general X ij given a similar amendment, namely that
ij . In summary, this paper describes the stepped wedge design in terms of experimental design concepts, which has enabled the form and nature of the treatment effet estimator to be made explicit and its properties more clearly understood. Starting from a row-column design with S rows and T columns comparing two treatments, and with a single continuous outcome y st in the sth row and tth column, then the model in (1) can be written in matrix form as y = Xζ + η, where the parameters are written in vector form as ζ T = (α T , β T , θ) and the design matrix is
where D 1 is an ST -dimensional vector of 0s and 1s indicating treatment allocation and 1 m denotes an m-dimensional vector of 1s. The least squares estimator of ζ is (X T X) − X T y, where A − is a g-inverse of A: in order to obtain an expression for the estimator of θ, we need to consider partitions of (X T X) − and X T y. If we denote the m × n matrix of 1s by J m,n , then
where Application of standard results on partitioned matrices then shows that the estimate of the treatment effect from the row-column model isθ
where y (1) is the sum of the y st which have received treatment 1, y R is the vector of row sums of the y st , i.e. the sth element of y R is T t=1 y st and y C is the vector of column sums, and y G is the sum of all the y st . From this it can be seen that the coefficient matrix a RC st is proportional to ST D st − SR 1s − T C 1t + G 1 . The corresponding expression when the row effect is omitted from the model iŝ
indicating that a C st is now proportional to SD st − C 1t . For the case of three treatments, and for the case of random cluster effects, it is useful to make the following definitions: d RC as the denominator of (A1), d C to be T times the denominator of (A2) and Q = d RC /d C .
Three-treatment case
For row-column designs which compare a standard treatment with two new treatments, the design matrix can be extended to
If D is a design with three treatments, then the coefficient matrices forθ 1 andθ 2 can be written as linear combinations of the coefficient matrices, a(1) and a(2) for, respectively, the two-treatment sub-designs, D1 and D2 defined in Section 6.1.
As stated above we have θ 1 1 (row-column).
Here Q 1 is the value of Q the sub-design D1 and Q 2 is the corresponding quantity for D2. For three-treatment designs we also need Q 12 , defined as In substituting this expression in (A5) the factor σ −2 (1 − ψ) −1 cancels, so can be ignored in the calculations. This giveŝ
.
Comparing the elements of this expression with those for the vertical and row-column analyses, namely (A1) and (A2), it is readily seen that the above estimator can be written as a weighted mean of the vertical and row-column estimators, and that the coefficient matrix can be written as (5).
The result for three treatments proceeds analogously, giving
If M ij denotes the (i, j)th element of M , then the elements of the vector on the right hand side of (A6), divided, respectively, by M 11 and M 22 , are the estimators of θ 1 , respectively θ 2 , from the sub-designs D1 and D2. These can be re-cast as coefficient matrices and so provide the expression in (12) .
